Protocol summary

Study aim
Determining and comparing the effect of carboxytherapy in the treatment of stress urinary incontinence and sexual dysfunction
Design
A randomized, Single-blinding clinical trial, with the parallel groups, Phase 3 on 60 patients
Settings and conduct
In this single-blind randomized clinical trial, 60 women eligible for inclusion in the study that refer to the clinic of Al-Zahra and Kashani hospitals in Isfahan will be included in the study and randomly divided into 2 groups. The first group will receive carbon dioxide(CO2) injection in the vaginal tissue, and the second group as the control group will not receive this treatment. Then, the score of stress urinary incontinence and the score of their sexual dysfunction in both groups will be compared.
Participants/Inclusion and exclusion criteria
Inclusion criteria consist of women with stress urinary incontinence or sexual dysfunction, within the age range of 35-65 years, and at least one vaginal delivery or cesarean section. Exclusion criteria include active vaginal bleeding, vaginal infection, abnormal Pap smear, pregnancy, urinary tract infection, recent pelvic surgery, grade 2 or more pelvic organ prolapse, and treatment with antiplatelet or anticoagulant drugs.
Intervention groups
Intervention group: In this group, an injection angle of 15 degrees will inject 30 cc of carbon dioxide (CO2) in three areas of the vagina. Each person will undergo carboxytherapy twice a week for 2 months. Control group: In this group, an injection angle of 15 degrees will be inserted in three areas of the vagina, but carbon dioxide (CO2) will not be injected. It should be noted that the insertion of the needle into the vaginal tissue even without the injection of carbon dioxide (CO2) stimulates collagen production and is not harmful to the patient.
Main outcome variables
Stress urinary incontinence score; Sexual dysfunction score

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20200825048515N27
Registration date: 2021-04-03, 1400/01/14
Registration timing: prospective

Last update: 2021-04-03, 1400/01/14
Update count: 0
Registration date
2021-04-03, 1400/01/14
Registrant information
Name
Asieh Maghami Mehr
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 31 0000 0000
Email address
asimaghami@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-04-20, 1400/01/31
Expected recruitment end date
2021-07-22, 1400/04/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the effect of carboxytherapy in the treatment of stress urinary incontinence and sexual dysfunction
Public title
The effect of carboxytherapy in the treatment of stress urinary incontinence and sexual dysfunction
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
women with stress urinary incontinence or sexual dysfunction within the age range of 35-65 years Have at least one vaginal delivery or cesarean section
Exclusion criteria:
Having active vaginal bleeding Having vaginal infection Having abnormal Pap smear Pregnancy Having urinary tract infection Recent pelvic surgery Having grade 2 or more pelvic organ prolapse Treatment with antiplatelet or anticoagulant drugs
Age
From 35 years old to 65 years old
Gender
Female
Phase
3
Groups that have been masked
  • Investigator
  • Data analyser
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, 60 eligible patients will be randomly selected. Then random numbers are created by computer software "Random Allocation". We randomly divide these numbers into two parts. Each number is written on paper and placed in an envelope. Then each patient is asked to choose an envelope from among the envelopes. According to the selected envelope, the patient will be assigned to one of the two groups.
Blinding (investigator's opinion)
Single blinded
Blinding description
Due to the fact that in this study, carbon dioxide (CO2) is injected in three areas of the vagina in one group and a needle is inserted in three areas of the vagina in the other group, but no injection is performed, so the researcher will be aware of the type of intervention. But due to the similarity in performance, the patient does not know the type of intervention. Also, the statistical analyst will not be aware of the type of intervention.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Isfahan University of Medical Sciences
Street address
Street address Isfahan University of Medical Sciences, Hezar Jarib Ave., Azadi Sq
City
Isfahan
Province
Isfehan
Postal code
8179964167
Approval date
2020-12-04, 1399/09/14
Ethics committee reference number
IR.MUI.MED.REC.1399.795

Health conditions studied

1

Description of health condition studied
Sexual dysfunction
ICD-10 code
F52
ICD-10 code description
Sexual dysfunction not due to a substance or known physiological condition

2

Description of health condition studied
Stress urinary incontinence
ICD-10 code
N39.3
ICD-10 code description
Stress incontinence

Primary outcomes

1

Description
Urinary stress incontinence score
Timepoint
Before, one and three months after the intervention
Method of measurement
Questionnaire-Urinary Incontinence Short Form(ICIQ-UI SF)

2

Description
Sexual dysfunction score
Timepoint
Before, one and three months after the intervention
Method of measurement
Short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: In this group, a 30 gauge needle with a length of 12 mm and an injection angle of 15 degrees will inject 30 cc of carbon dioxide (CO2) in three areas of the vagina. Each person will undergo carboxytherapy twice a week for 2 months.
Category
Treatment - Other

2

Description
Control group: In this group, a 30 gauge needle with a length of 12 mm and an injection angle of 15 degrees will be inserted in three areas of the vagina, but carbon dioxide (CO2) will not be injected. It should be noted that the insertion of the needle into the vaginal tissue even without the injection of carbon dioxide (CO2) stimulates collagen production and is not harmful to the patient.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Kashani Hospital
Full name of responsible person
Zahra Allameh
Street address
Obstetrics and Gynecology Department, Kashani Hospital, Kashani Street.
City
Isfahan
Province
Isfehan
Postal code
8183983434
Phone
+98 31 3233 0091
Email
z-allameh@med.mui.ac.ir

2

Recruitment center
Name of recruitment center
Al-Zahra Hospital
Full name of responsible person
Zahra Allameh
Street address
Soffe Blvd, Isfahan
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3620 2020
Email
z-allameh@med.mui.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Shaghayegh Haghjoo Javanmard
Street address
Vice Chancellor for Research, School of Medicine, Hezar Jarib Street, Isfahan.
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 8597
Email
dean@med.mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Isfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Zahra Allameh
Position
Associate Professor
Latest degree
Subspecialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Department of Obstetrics and Gynecology, Al-Zahra Hospital, Sofeh Blvd., Tohid Street
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3620 2020
Email
z-allameh@med.mui.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Zahra Allameh
Position
Associate Professor
Latest degree
Subspecialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Department of Obstetrics and Gynecology, Al-Zahra Hospital, Sofeh Blvd., Tohid Street
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3620 2020
Email
z-allameh@med.mui.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Maryam teimouri jervekani
Position
resident
Latest degree
Specialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Department of Obstetrics and Gynecology, Al-Zahra Hospital, Sofeh Blvd., Tohid Street
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3620 2020
Email
Maryam_tymr@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
There is no further information
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
No - There is not a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Loading...